|
FDA Approvals-New Drugs, Diagnostics and Devices
Approved Drug-Electronic Orange Book-Search Approved Drug Products-
with Therapeutic Equivalence Evaluations, Current through February 2007
Date:
02/01/2007
, Publication:
FDA
, Author:
FDA
http://www.fda.gov:80/cder/ob/default.htm
Obsessive-Compulsive Disorder: FDA Approves Humanitarian Device Exemption for Deep Brain Stimulator for Severe Obsessive-Compulsive DisorderDate:
02/25/2009
, Publication:
FDA
, Author:
FDA News
http://www.fda.gov/bbs/topics/NEWS/2009/NEW01959.html
Encephalitis-FDA Approves New Vaccine to Prevent Japanese EncephalitisDate:
04/01/2009
, Publication:
FDA
, Author:
FDA News
http://www.fda.gov/bbs/topics/NEWS/2009/NEW01981.html
Kidney Cancer-FDA Approves Drug for an Advanced Form of Kidney CancerDate:
03/31/2009
, Publication:
FDA
, Author:
FDA News
http://www.fda.gov/bbs/topics/NEWS/2009/NEW01980.html
Biologic-FDA CDER Drug and Biologic Approvals for Calendar Year 2006
Updated through October 31, 2006
Date:
11/15/2006
, Publication:
FDA-CDER
, Author:
FDA
http://www.fda.gov/cder/rdmt/InternetNDA06.htm
Therapeutic Equivalence-FDA Approved Drug Products with Therapeutic Equivalence Evaluations
Orange Book
Date:
11/17/2006
, Publication:
FDA-CDER
, Author:
FDA
http://www.fda.gov/cder/orange/default.htm
Cystic Fibrosis-FDA Approves Inhaled Antibiotic for Management Of Cystic Fibrosis Patients
Cystic fibrosis is an inherited condition that causes thick mucous secretions in the lungs, resulting in severely diminished lung function and chronic lung infections...
Date:
12/22/1997
, Publication:
FDA-HHS
, Author:
Susan M. Cruzan
http://www.fda.gov/bbs/topics/NEWS/NEW00610.html
Skin Cancer-FDA Approves New Drug for Skin Cancer, Zolinza
Evidence of Zolinza's safety and effectiveness was developed in two clinical trials
Date:
10/06/2006
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01484.html
Vaccine-FDA Approves New Vaccine to Prevent Rotavirus Gastroenteritis in Infants
Infection with rotavirus is a leading cause of severe diarrhea in infants and young children in the United States and worldwide
Date:
02/03/2006
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/news/2006/NEW01307.html
Pulmonary-FDA Approves New Orphan Drug for Treatment of Pulmonary Arterial Hypertension
(FDA) today approved Letairis (ambrisentan) for the treatment of pulmonary arterial hypertension, a rare, life-threatening condition characterized by continuous high blood pressure within the arteries of the lungs.
Date:
06/15/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01653.html
Previous
Page 1 of 12
Next >
Search returned 120 items.
|
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
Clinical Researchers, others from
subscriber lists and assoc's.
www.biotechmedia.com
|